Diagnostic Method Segment Analysis: Conventional Method (Largest Segment) vs Molecular/Modern Method (Fastest-Growing Segment)

The conventional method segment dominated the neglected tropical diseases diagnosis market with a 53.55% share in 2026, supported by its established role in disease identification across regions where diagnostic infrastructure and resources can vary considerably. Conventional approaches are often familiar to healthcare personnel, supported by existing laboratory practices, and applicable in settings where advanced diagnostic technologies may not be readily accessible. Their established workflows and relatively straightforward implementation make them valuable for routine diagnosis and disease surveillance. Continued public-health efforts to expand testing coverage and improve detection of neglected infections are sustaining the relevance of conventional diagnostic methods, particularly in resource-constrained environments.

Molecular/Modern methods are the fastest-growing diagnostic approaches as healthcare systems increasingly seek greater diagnostic precision, sensitivity, and the ability to identify infections more rapidly. Modern techniques can provide more detailed information than traditional approaches and are increasingly relevant where accurate disease differentiation is important for appropriate clinical management. Improvements in laboratory technology, growing investment in diagnostic infrastructure, and greater emphasis on early detection are supporting their adoption. The expanding focus on disease surveillance and improved identification of infections that may be difficult to detect using conventional approaches is further encouraging the transition toward molecular and other modern diagnostic technologies.

Service Type Segment Analysis: Centralized Service (Largest Segment) vs POC Service (Fastest-Growing Segment)

Centralized service held the largest share of 62.93% in 2026, reflecting the continued importance of specialized laboratories in performing diagnostic testing for neglected tropical diseases. Centralized facilities can consolidate laboratory expertise, equipment, quality-control procedures, and testing capabilities, making them suitable for complex diagnostic workflows and broader disease surveillance programs. Their ability to process samples using established laboratory infrastructure also supports consistent testing across healthcare networks. In regions where advanced diagnostic resources are concentrated in specialized facilities, centralized services remain an important mechanism for expanding access to reliable testing while maintaining laboratory quality and technical expertise.

POC service is the fastest-growing segment as healthcare providers increasingly seek diagnostic solutions that can deliver results closer to patients and reduce reliance on centralized laboratory workflows. Point-of-care testing can be particularly valuable in geographically remote or resource-limited settings, where transporting samples to distant laboratories may delay diagnosis and treatment decisions. Faster access to diagnostic information can strengthen clinical responsiveness and support earlier intervention. Growing efforts to decentralize healthcare delivery, improve testing accessibility, and strengthen disease detection at community and frontline healthcare levels are creating favorable conditions for broader adoption of point-of-care diagnostic services.